World's Best Scientists 2026 revealed!
Cancer Genomics and Proteomics
H-index 17

Cancer Genomics and Proteomics

1109-6535

Published by: International Institute of Anticancer Research

https://cgp.iiarjournals.org/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1841 41 93 14

Additional Metrics

Number of Best Scientists*: 90
Documents by Best Scientists*: 147
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 51
SCIMAGO SJR: 0.697
Impact Factor: 2.6

Overview

Top Research Topics at Cancer Genomics & Proteomics?

Cancer Genomics & Proteomics primarily focuses on research topics in Cancer research, Cancer, Internal medicine, Gene and Oncology. The research on Cancer research featured in Cancer Genomics & Proteomics combines topics in other fields like Immunohistochemistry, Pathology, Cell culture, Cancer cell and Metastasis. Cancer study tackled is connected to the field of Bioinformatics.

Cancer Genomics & Proteomics explores issues in Internal medicine which can be linked to other research areas like Endocrinology and Genotype. The work tackled in it goes beyond the discipline of Genotype as it also encompasses Allele. The studies tackled, which mainly focus on Gene, apply to Molecular biology as well.

Cancer Genomics & Proteomics focused on Molecular biology research but expanded to cover Proteomics. It features Oncology research that overlaps with concepts in Biomarker (medicine).

  • Cancer research (36.90%)
  • Cancer (20.03%)
  • Internal medicine (19.20%)

What are the most cited papers published in the journal?

  • Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. (257 citations)
  • Applications of Support Vector Machine (SVM) Learning in Cancer Genomics. (250 citations)
  • Breast cancer metastasis. (223 citations)

Research areas of the most cited articles at Cancer Genomics & Proteomics:

The most cited publications generally zeroe in on subjects such as Cancer research, Cancer, Internal medicine, Oncology and Metastasis. While the journal papers focused on Cancer research, they were also able to explore topics like Cancer cell, Gene expression, Immunology and Microvesicles. While Cancer is the focus of the journal publications, it also provides insights into the studies of Molecular biology, Bioinformatics and Pathology.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Enzyme

The previous edition focused in particular on these issues:

The journal mostly deals with topics like Cancer research, Cancer, Oncology, Internal medicine and Apoptosis. In the journal, Protein kinase B, microRNA, Metastasis, Lung cancer and Kinase are investigated in conjunction with one another to address concerns in Cancer research research. It features studies on Cancer, including topics such as Cancer cell.

In addition to Oncology research, it aims to explore topics under Radioresistance, Radiation therapy, CDKN2A, Genotype and Colorectal cancer. Internal medicine research discussed connects with the study of Precision medicine. Topics in Apoptosis explored in it were investigated in conjunction with research in Clinical prognosis and Pathogenesis.

The most cited articles from the last journal are:

  • Noncoding RNAs Serve as the Deadliest Universal Regulators of all Cancers. (4 citations)
  • microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis. (3 citations)
  • Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Genomics & Proteomics (based on the number of publications) are:

  • Ulrich H. Weidle (37 papers) published 4 papers at the last edition the same number as at the previous edition,
  • Wen Guo Jiang (25 papers) absent at the last edition,
  • Sverre Heim (21 papers) published 4 papers at the last edition, 3 less than at the previous edition,
  • Ioannis Panagopoulos (21 papers) published 4 papers at the last edition, 3 less than at the previous edition,
  • Ludmila Gorunova (17 papers) published 1 paper at the last edition, 6 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Genomics & Proteomics (based on the number of publications) are:

  • Hoffmann-La Roche (38 papers) published 4 papers at the last edition the same number as at the previous edition,
  • National and Kapodistrian University of Athens (24 papers) published 3 papers at the last edition the same number as at the previous edition,
  • China Medical University (Taiwan) (24 papers) published 3 papers at the last edition, 3 less than at the previous edition,
  • Cardiff University (23 papers) absent at the last edition,
  • University of Oslo (22 papers) published 3 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.70% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.69% were posted by at least one author from the top 10 institutions publishing in the journal. Another 15.38% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.38% of all publications and 36.54% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction

    (2021)
    64 Citations
  • Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone

    (2022)
    35 Citations
  • NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma.

    Ioannis Panagopoulos;Ludmila Gorunova;Kristin Andersen;Marius Lund-Iversen

    (2020)
    34 Citations
  • PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.

    Takashi Higuchi;Takashi Higuchi;Jun Yamamoto;Norihiko Sugisawa;Yoshihiko Tashiro

    (2020)
    28 Citations
  • Oncogenes and Methionine Addiction of Cancer: Role of c-MYC

    (2023)
    21 Citations
  • Biological Effect of Silver-modified Nanostructured Titanium Dioxide in Cancer.

    Nefeli Lagopati;Nefeli Lagopati;Nefeli Lagopati;Athanassios Kotsinas;Dimitris Veroutis;Dimitris Veroutis;Konstantinos Evangelou

    (2021)
    21 Citations
  • Deletion of MTAP Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase

    (2022)
    21 Citations
  • Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.

    Yusuke Aoki;Yusuke Aoki;Jun Yamamoto;Jun Yamamoto;Yasunori Tome;Kazuyuki Hamada

    (2021)
    20 Citations
  • Increased Expression of Gremlin1 Promotes Proliferation and Epithelial Mesenchymal Transition in Gastric Cancer Cells and Correlates With Poor Prognosis of Patients With Gastric Cancer.

    Zhiwei Sun;Shuo Cai;Chang Liu;Yuxin Cui

    (2020)
    19 Citations
  • KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma.

    Akihiro Kitagawa;Akihiro Kitagawa;Takaaki Masuda;Junichi Takahashi;Taro Tobo

    (2020)
    18 Citations

Related Online Degrees & Career Pathways

For those interested in medicine but exploring alternative or complementary career routes, nursing degrees offer flexible and accelerated options. Many registered nurses seek to advance their qualifications quickly with programs like rn to bsn 6 months programs, which allow completion of a Bachelor of Science in Nursing in just half a year.

Additionally, bridge programs such as asn to np programs enable Associate Degree Nurses to transition directly to Nurse Practitioner roles, expanding their scope of practice and career opportunities.

For individuals without a nursing background, direct entry msn programs for non-nurses online provide a pathway to earn a Master of Science in Nursing online, offering a fast-track into nursing leadership and advanced clinical roles.

When choosing the right online nursing program, comparing options is crucial. Resources comparing universities, such as capella vs wgu rn to bsn programs, help prospective students make informed decisions based on program length, cost, and flexibility.

Best Scientists Contributing to This Journal

Recently Published Articles